Union College

Union | Digital Works
Honors Theses

Student Work

6-2022

Implications of Antibiotic and Bacteriophage Resistance in
Environmentally Isolated E. coli
Michael Connolly
Union College - Schenectady, NY

Follow this and additional works at: https://digitalworks.union.edu/theses
Part of the Bacteriology Commons, Biology Commons, and the Virology Commons

Recommended Citation
Connolly, Michael, "Implications of Antibiotic and Bacteriophage Resistance in Environmentally Isolated E.
coli" (2022). Honors Theses. 2620.
https://digitalworks.union.edu/theses/2620

This Open Access is brought to you for free and open access by the Student Work at Union | Digital Works. It has
been accepted for inclusion in Honors Theses by an authorized administrator of Union | Digital Works. For more
information, please contact digitalworks@union.edu.

Implications of Antibiotic and Bacteriophage Resistance in
Environmentally Isolated E. coli

By Michael H. Connolly

_______________________

Department of Biological Sciences
Advisor: Professor Lauzon
Union College
June 4, 2020

1

Abstract
The increasing prevalence of antibiotic-resistant bacteria is an emerging problem for
humans. Clinical misuse, overuse in agricultural and food settings, and limited numbers of new
antibiotics have accelerated the proliferation of antibiotic-resistant bacteria. To confront this
threat, scientists must develop new therapeutics that kill these antibiotic-resistant bacteria. In this
study, we used Escherichia coli to analyze antibiotic and bacteriophage susceptibility. E. coli is a
common, mostly benign, enteric, gram-negative bacteria. We isolated three E. coli strains from
the Hans Groot Kill, a stream that runs through Union College’s campus. We sought to assess
various E. coli strains’ antibiotic resistance, susceptibility to bacteriophages, and underlying
resistance mechanisms. We compared the environmental E. coli isolates to known lab strains of
E. coli. Using T4 bacteriophage, a well characterized viral pathogen that carries out a lytic cyle
in E. coli bacteria, we conducted modified plaque assays with the three environmental isolates
and lab strains “B” and “C.” The environmental isolates were found to be highly resistant to T4
phage, while the lab strains were susceptible. We also conducted Kirby-Bauer antimicrobial disk
susceptibility tests, using various gram-negative targeted drugs. We found the lab strains to be
highly susceptible to all of the antibiotics, while the environmental isolates showed intermediate
resistance to some of the antibiotics. Surprisingly, both environmental and lab strains were
encapsulated. These patterns of resistance to phages and antimicrobial drugs suggest that
environmental E. coli strains must have some mechanism for resistance that could be exploited
as a novel means of treating drug-resistant infections.
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Introduction
Background
Since Alexander Fleming’s accidental discovery of penicillin in 1928, there has been a
rapid and explosive increase in the development of antimicrobial drugs (Aminov, 2010).
Antimicrobial drugs comprise many chemicals that target a bacterial cell to kill it or arrest its
growth. These new drugs have proved almost miraculous for many patients infected with
previously fatal bacterial diseases.
The use of antimicrobial drugs has not been solely restricted to medical settings. Large
scale industrial farming commonly uses large quantities of antimicrobial drugs in raising
livestock (Manyi-Loh et al., 2018). Antimicrobial drugs are frequently overused in these largescale farms, and eventually end up polluting the environment through animal waste (ibid.). This
form of antimicrobial drug abuse is thought to lead to the natural selection for and the
proliferation of resistant bacterial strains (ibid.). Since many of the bacteria that are present in
livestock are pathogenic in humans, the emergence of resistant bacterial strains in livestock, and
their increasing prevalence in the environment, have significant health ramifications for humans
(ibid.).
In the twenty-first century, the proliferation of single and increasingly multi-drug
resistant bacteria has challenged the healthcare system’s reliance on antimicrobial drugs (Llor &
Bjerrum, 2014). The erroneous prescription of antibiotics for viral infections and self-limiting
bacterial infections, the failure to persist in taking a full course of antibiotics, and the excessive
use of antimicrobial drugs in agriculture and aquaculture settings have led to the increase in
number of antimicrobial drug-resistant bacteria (ibid.). The discovery and approval of new
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antibiotic drugs have decreased by 90% over the last thirty years because of the time and costprohibitive nature of this process (Vera-Mansilla et al., 2022). These developments have reduced
the effectiveness of antimicrobial drugs in treating infections.
Antimicrobial drug resistance can be mitigated, but not eliminated by responsible drug
use. In many developing countries, antibiotics are available over the counter, and are thus prone
to irresponsible use (Manyi-Loh et al., 2018). The diverse genome of bacteria means that every
antimicrobial drug class ever developed has been met by resistance when tested on bacteria
(Larsson & Flak, 2018). This indicates that, even with well-regulated antimicrobial drug
schedules, these drugs have inherent limits, and alternate treatments must be explored in order to
most effectively treat bacterial infections.
In 1917, Félix d'Hérelle developed a procedure to isolate particles that he named
“bacteriophages” or simply “phages” from bacterial cultures. He was unaware of the exact nature
of these particles, but their antimicrobial effect was apparent. Two years later, d'Hérelle
successfully used phages to cure avian typhosis in a chicken. This was the first successful use of
phage therapy (Summers, 1999). The principle behind phage therapy is simple. Like all living
organisms, bacteria have viral parasites that selectively infect, replicate inside, and kill their
hosts. Phage therapy uses viruses of bacteria, d'Hérelle’s phages, to infect a bacterial infection in
a human or animal host and thereby cure the disease.
As bacteria have become increasingly resistant to antimicrobial drugs, phage therapy is
increasingly seen as a promising alternative treatment. Phages have been shown to infect and
lyse clinically isolated bacteria strains, indicating the possibility for phage use in medical
treatments of antibiotic-resistant bacterial strains (Sundar et al., 2009). Phages have high host
specificity, meaning that a phage will not produce resistance in non-targeted bacterial strains,
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unlike many broad-spectrum antibiotics (ibid.). While phage therapy is currently in medical use
in several former Eastern Bloc countries: Poland, Russia, and the Republic of Georgia, it has
only reached the clinical trial stage in the United States and other Western nations (Furfaro et al.,
2018; Żaczek et al., 2020).

Escherichia coli and T4 Phage
One of the most studied bacterial species is Escherichia coli. E. coli is a Gram-negative,
rod-shaped, facultative anaerobe that is commonly found in the gastrointestinal tract of humans
and other mammals (Anderson et al., 2019). Its presence in water indicates fecal contamination
(Sora et al., 2021). Some strains of E. coli, such as O157:H7, are extremely virulent, and can be
spread rapidly through contaminated water (Rahal et al., 2012). E. coli is the main causative
agent of urinary tract infections (UTI), the second most common bacterial infection. UTIs are so
common that approximately 50% of women will have a UTI at some point in their lives. As in
other bacteria species, recent decades have seen a marked increase in antibiotic resistance in E.
coli strains (Vera-Mansilla et al., 2022). These factors make E. coli a relevant bacterium to study
regarding antimicrobial drug and phage resistance.
E. coli’s role as an indicator organism for fecal contamination makes it an excellent
candidate for an indicator of antimicrobial drug resistance in the environment (Anjum et al.,
2021). Human and animal feces can enter streams and rivers through various processes including
sewer overflow, agricultural and urban runoff, and direct animal defecation (Boehm &
Sassoubre, 2014). Because E. coli is so common in humans and animals, it is frequently exposed
to antimicrobial drugs, regardless of whether it is the intended target (Larsson & Flak, 2018).
This exposure inevitably leads to the development of antimicrobial drug resistant bacteria strains
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(ibid.). Study of antimicrobial resistance in E. coli strains isolated from the environment will thus
provide insight into the presence of antimicrobial drug resistant E. coli in the environment, and
may lead to the development of alternate treatments, such as phage therapy, E. coli infections in
humans and animals.
To develop an assay that would explore the potential for phage therapy, we analyzed T4
phage’s infectivity in E. coli strains isolated from the environment. T4 phage is a well-studied
model lytic bacteriophage that is a pathogen of E. coli. Belonging to the family Myoviridae, T4
phage is physically and genetically similar to T2 phage and T6 phage and is thus classified as a
T-even phage (Anderson et al., 2019). T4 phage’s structure is composed of three main structures:
a capsid, containing double-stranded DNA; a long cylindrical tail; and a series of six tail fibers
(Yap et al., 2014; Anderson et al., 2019). T4 phage acts as a molecular syringe to infect a cell. T4
binds in a two-step process to E. coli’s outer membrane; first, it reversibly binds to the outer
membrane’s lipopolysaccharide (LPS), then irreversibly binds to a phage receptor in the outer
membrane; this secondary receptor varies by strain and can be outer membrane proteins, porins,
flagella, or even the bacterium’s capsule (Soundararajan et al., 2019; Gonzalez et al., 2014).
After binding to the cell, a protein on T4’s cell puncturing device bores a hole in the membrane
and injects T4’s DNA into the host cell (Yap et al., 2014). T4 phage propagates in a lytic cycle,
wherein after adsorbing to the host cell and injecting its DNA, the host cell is hijacked to
assemble new T4 phage virions and then lyse, expelling virion progeny that can initiate a new
lytic cycle into the environment (Howard-Varona et al., 2017).

7

Our Study
In our study, we analyzed E. coli bacteria collected from the Hans Groot Kill, an urban
stream in Schenectady, New York. We were drawn to this body of water on the basis of previous
studies that had indicated that the Hans Groot Kill was highly contaminated with enteric bacteria.
The source of this bacteria is unknown, but it is thought that Schenectady’s aging sewer system
contributes to this pollution. This means that humans are likely the ultimate source of the
stream’s contamination. After flowing through Schenectady, the Hans Groot Kill flows into the
Mohawk River, thus contaminating the source of drinking water for some communities
downriver (Willard-Bauer, 2021).
Our study aimed to analyze phage and antimicrobial resistance in E. coli using T4 phage
and a panel of Gram-negative bacteria targeted antimicrobial drugs. The antimicrobial drug and
phage susceptibility patterns of well-studied E. coli lab reference strains B and C were compared
to those of E. coli environmental isolates from the Hans Groot Kill. Since these environmental
isolates have a likely origin in the gut of humans or animals, this study has medical and industrial
significance. E. coli environmental isolates come from a much harsher environment compared to
lab strains. We reasoned that E. coli environmental isolates would be much more accustomed to
competing with phages and other microbes for survival, and environmental isolates, through their
human hosts, had been exposed to antimicrobial drugs and survived; thus, it was expected that
environmental isolates would have strong resistance mechanisms to phages and/or antimicrobial
drugs.
We analyzed T4 phage susceptibility in E. coli environmental isolates using a modified
version of the small drop plaque assay described by Mazzocco et al. (Kropinski et al., 2009).
This assay enabled us to serially dilute our T4 phage solution, and thereby assess bacterial
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susceptibility to T4 phage at multiple concentrations. Antimicrobial drug susceptibility in our E.
coli environmental isolates was assessed by performing a Kirby-Bauer susceptibility test, using a
panel of Gram-negative specific drugs. Our aim was to assess whether environmentally isolated
E. coli displayed resistance to antimicrobial drugs, and how this compared to their pattern of T4
phage susceptibility.
A well-studied resistance mechanism to both phages and antimicrobial drugs in bacteria
is encapsulation. Encapsulated bacteria are surrounded by a polysaccharide layer that can act as
an additional barrier to prevent phage adsorption and penetration of antimicrobial drugs into the
cell. A study by Soundararajan et al. (2019) compared T4 susceptibility in a genetically modified
capsule knockout E. coli strain Nissle 1917 to encapsulated E. coli strain Nissle 1917 and found
that the unencapsulated bacteria were significantly more susceptible to T4 phage. We considered
encapsulation as an easily testable mechanism that might explain differential phage and
antimicrobial drug susceptibility in E. coli lab strains and environmental isolates.
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Materials and Methods
Materials
Growth Media:
Growth media were purchased from VWR (Radnor, PA). E. coli lab strains and
environmental isolates were maintained on BD DIFCO™ Tryptic Soy Agar (TSA) slants. In
addition, BD DIFCO™ Tryptic Soy Agar (TSA) was supplemented with 1.5 mM calcium
chloride and used as a growth medium in our small drop plaque assays. We used BD BBL™
Lactose Broth in our lactose fermentation tests, and BD BBL™ EMB Agar in our E. coli colony
isolation tests. 1.5 mM Ca2+ BD BBL™ Tryptic Soy Broth (TSB) was used as a growth medium
for our growth rate assays, small drop plaque assays, and Kirby-Bauer testing. We used BD
BBL™ Mueller-Hinton Agar to perform our Kirby-Bauer testing.
Organisms and Phage
Laboratory strains of Escherichia coli B and C were obtained from Carolina Biological
Supply (Burlington, NC) and grown on tryptic soy agar (TSA) slants supplemented with 1.5 mM
calcium chloride. T4 bacteriophage suspension was obtained from Ward’s Science (Rochester,
NY) at a titer of 3 x 107 plaque forming units (PFU)/ml.
Antibiotic Testing
Kirby-Bauer testing was performed using six different types of antimicrobial druginfused disks: tetracycline, kanamycin, sulfadimethoxine, chloramphenicol, nalidixic acid, and
nitrofurantoin (Ward’s Science, Rochester, NY).
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Methods
Isolation of E. coli Environmental isolates
Through several tests conducted in a sequence, three E. coli strains were isolated from the
Hans Groot Kill in Schenectady, NY. First, sterile glass bottles were filled with water samples
collected from the Hans Groot Kill and this water was used to inoculate 5 ml lactose broth tubes
each containing an inverted Durham tube. The lactose broth was incubated overnight at 37℃.
A positive test (acid and gas production) indicated the presence of a lactose fermenting
bacterium. EMB agar plates were subsequently quadrant-streaked with inocula from positive
lactose broth tubes and incubated overnight at 37℃. Discrete colonies with a metallic sheen
appearance were picked and transferred onto tryptic soy agar (TSA) slants and grown overnight
at 37℃. These isolates were labeled “1,” 2A,” and “2B” (isolates 2A and 2B came from three
separate colonies on the same EMB plate; strain 1 came from a second EMB plate). Gram stains
were carried out on cultures of each isolate grown in TSB at 37℃ for 24 hours. EnteroPluriTests (Becton, Dickinson & Company, Sparks, MD) were individually inoculated with inocula
from each isolate to determine species identity.
Growth Rate determination
TSB tubes were inoculated with each E. coli strain and incubated for 24 hours at 30oC.
The following day, 50 μl of bacterial suspension was inoculated into sterile 5 ml TSB
spectroscopy tubes and subsequently incubated in a shaking incubator at 37oC. Absorbance
readings for each culture tube was determined by spectrophotometry at a wavelength of 600 nm
every 30 minutes for a maximum of 6 hours.
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Kirby-Bauer Antimicrobial drug sensitivity
TSB tubes were inoculated with E. coli lab strains and environmental isolates, and
incubated for 24 hours at 30℃. New sterile 5 ml TSB tubes were inoculated with 50 μl of
bacterial suspension from the 24-hour cultures and incubated in a shaking incubator at 37oC for
two hours to achieve log phase of growth. Using sterile cotton swabs, 3+1 swabbing of MuellerHinton agar plates was carried out with each E. coli culture. Two plates were swabbed for each
E. coli strain. Three antimicrobial disks were placed on each plate, with a blank disk in the
middle of each plate to serve as control. This assay was performed using six different antibiotics:
tetracycline, kanamycin, sulfadimethoxine, chloramphenicol, nalidixic acid, and nitrofurantoin.
The plates were inverted and incubated for 24 hours at 37oC. Diameters for zones of inhibition
were measured for each antibiotic.
Small drop Plaque Assay Protocol
5 ml TSB broth tubes were inoculated with E. coli B and C strains as well as
environmental isolates and incubated for 24 hours at 30℃. New sterile 5 ml TSB tubes were
inoculated with 50 μl of bacterial suspension from the 24-hour cultures and incubated in a
shaking incubator at 37oC for two hours to achieve log phase of growth, as described above.
Serial dilutions were prepared in a series of ten microfuge tubes for each bacterial strain
tested. 180 μl sterile TSB was added to the first dilution tube, whereas 100 μl of sterile TSB was
added to tubes 2-10. 20 μl of T4 phage suspension was pipetted into tube 1 and mixed to ensure
even resuspension. A 100 μl volume was transferred from the first tube into the second tube,
mixed and serial, two-fold dilutions were carried out in tubes 3-8. Tubes 9 and 10 did not contain
phage and served as controls. A volume of 11 μl from each two-hour E. coli culture was added to
tubes 1-10. The solutions in each tube were gently mixed as described and incubated for 20
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minutes at 37℃ to allow for phage adsorption onto bacterial cells. Individual TSA plates were
divided into 10 sections each, labeled 1-10 and performed in duplicate for each strain. A 20 μl
volume from each tube was pipetted onto their corresponding section on each TSA plate. Plates
were allowed to dry and subsequently incubated overnight for 24 hours at 37℃. Presence or
absence of plaques was visualized the following day; plaques appearing as clearance zones in the
bacterial lawn.
Anthony’s Method Capsule Stain
5 ml volumes of TSB tubes were inoculated with E. coli and incubated for 24 hours at
37℃. Microscope slides were first inoculated with a loopful of skim milk broth, then with a
loopful of E. coli overnight culture. Slides were allowed to air dry without heat fixation. Slides
were initially stained with a 1% crystal violet solution for two minutes, and then decolorized
with a 20% copper sulfate solution. These slides were allowed to air-dry and subsequently
viewed under oil immersion.
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Results
Isolation of E. coli environmental isolates
Water collected from the Hans Groot Kill was shown to contain lactose fermenting
bacteria through the lactose broth test (Figs. 1, 2). By quadrant streaking EMB agar plates with
inoculum from positive lactose broth tubes, we successfully isolated several discrete E. coli
colonies that displayed a characteristic greyish-green metallic sheen (Fig. 3). Each discrete
colony on the EMB agar plates contained the progeny of one E. coli cell from the lactose broth.
This meant that each discrete E. coli colony was a single E. coli strain, as all the cells in a
discrete colony are genetically identical. All of the strains were Gram negative rods, consistent
with the morphology and cell wall characteristics of E. coli (Fig. 4)
We used an EnterotubeTM to further analyze the metabolic properties of three different
colonies isolated from the EMB agar. Even though each colony was confirmed to belong to the
same species, E. coli, differences in lysine and ornithine decarboxylase activity as well as ability
to ferment the sugar dulcitol among the three strains indicated that the three colonies represented
different strains of E. coli (Table 1). This implied that genotypic differences existed among the
three environmental isolates of E. coli.

Growth Rate Assay
Our growth rate assay provided insight into the timing of E. coli’s different growth
phases. In a closed vessel system containing a defined concentration of nutrients within a set
volume, the bacterial growth curve follows characteristic stages which include a tooling up phase
(lag), an exponential growth phase (log), a stationary phase during which cell division ceases and
an exponential decline or death phase (Fig. 5). Our concern was identifying the delineation
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between the lag phase of E. coli growth and exponential or log phase of E. coli growth. The
growth rates of E. coli environmental isolates and lab strains mirrored the relationship between a
culture’s increasing absorbance at 600 nm over time. It is worth noting that measuring the
culture’s absorbance gives an estimate of the total number of cells and does not distinguish
between living and dead cells (Anderson et al., 2019). However, this technique was deemed
adequate for the purposes of our experiment to determine when E. coli’s log phase of growth
began.
The strains began their growths in lag phase as a plateaued slope (Fig. 6). After
approximately 1.5 hours, absorbance values from every E. coli strain began to increase rapidly.
This was determined to be the start of the log phase of growth. This growth phase continued for
approximately 4.5 hours, until the E. coli entered the stationary phase of growth (Fig. 6). Based
on this assay, all further experiments that tested antimicrobial or phage susceptibility on the E.
coli environmental isolates and lab strains used two-hour cultures of E. coli to ensure that the E.
coli were in their log phase of growth. It is well documented that bacterial sensitivity to
antimicrobial drugs is optimal during the log phase of growth (Eng et al., 1991; Bolger-Munro et
al., 2013; Anderson et al., 2019).
In addition, we observed differences in growth rates among the E. coli environmental
isolates and lab strains. Strain C, and to a lesser extent B, displayed less steeper slopes compared
to the E. coli environmental isolates, particularly environmental isolate 1 (Fig. 6). The faster
growth rate of some E. coli isolates lends credence to the idea that the environmental strains are
more robust than the E. coli lab strains.
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Kirby-Bauer Antibiotic Testing Assay
Lawns of the various strains of E. coli were incubated overnight with disks containing six
Gram negative-specific antimicrobial drugs (tetracycline, kanamycin, sulfadimethoxine,
chloramphenicol, nalidixic acid and nitrofurantoin) on Mueller-Hinton agar plates, after which
the diameters of the zones of inhibition were measured around each disk. A zone of inhibition is
a circular clearance area around an antimicrobial disk on Mueller-Hinton agar, where the drug
either kills or inhibits bacterial growth. Several observations were apparent from our initial
measurements. First, each E. coli environmental isolate and lab strain had some degree of
sensitivity to the antibiotics that we chose (Table 2). Therefore, our premise, that a two-hour E.
coli culture would be in its log phase of growth and therefore susceptible to antibiotics, was
correct. Second, apart from all three E. coli environmental isolates having intermediate resistance
to two of the antibiotics: tetracycline and nitrofurantoin, all E. coli environmental isolates and lab
strains were comparably susceptible to the four remaining drugs (Fig. 7, Table 2). Finally, we did
not see substantial numbers of revertant E. coli colonies growing within the zones of inhibition,
indicating these antibiotics were highly effective on our E. coli environmental isolates and lab
strains (Fig. 7).

Small drop Plaque Assay
When tested for their susceptibility to the bacteriophage T4 lytic cycle, we observed
noteworthy differences between the three E. coli environmental isolates and the two lab strains.
Our E. coli environmental isolates 1, 2A, and 2B demonstrated complete resistance to T4 phage,
with no discernible difference in E. coli growth from the highest phage concentration to the
lowest (Fig. 8). This was contrasted with the results from our E. coli lab strains B and C, which
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showed high levels of susceptibility to T4 phage at the highest phage concentrations (Fig. 8).
Interestingly, the small drop plaque assays with E. coli lab strains showed substantial numbers of
revertant colonies, or colonies that grew in the areas where the phage infections had taken place
(Fig. 8). This indicated that phage resistance was present in a small number of cells in the E. coli
lab strain populations.

Capsule Stain
The bacterial capsule is composed of a polysaccharide matrix that surrounds the cell wall
and serves as a protective barrier against biocides, including antimicrobial drugs and phages
(Fig. 9). We carried out capsule stains on lab and environmental strains to determine whether the
observed phage resistance could be explained by the selective expression of a capsule in the
environmental strains. Our findings revealed that individual, rod-shaped cells from both lab
strain C and isolate 2A were surrounded by a capsule (Fig. 10). The capsules appeared as clear
areas, resembling halos, around E. coli cells of both strains. Capsule stains carried on the other
two environmental isolates similarly revealed the presence of capsules surrounding individual
cells (data not shown). These findings indicate that, not only were the E. coli environmental
isolates encapsulated as we had predicted, but the E. coli lab strains were encapsulated as well
(Fig. 10).
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Discussion
Our experiments resulted in several important conclusions about antimicrobial and phage
resistance in our E. coli environmental isolates and created some new questions for future studies
to address. First, our E. coli environmental isolates did not possess widespread antimicrobial
drug resistance as we had predicted. Second, our E. coli environmental isolates were totally
resistant to T4 phage. Most significantly, we developed a series of procedures that enable rapid
screening for phage and antimicrobial resistance in E. coli environmental isolates.
It is important to note that our experiment was a pilot study, and was thus limited in its
scope and depth of analysis. One major limitation of our study was the small number of
environmental isolates of E. coli. Even though many studies have shown that bacterial strains
isolated from the environment frequently possess and express antimicrobial resistance genes, our
three E. coli environmental isolates’ phage and antimicrobial drug resistance patterns simply
may not reflect those of the thousands of E. coli strains that may be present in the Hans Groot
Kill or other environmental sources (Colomer-Lluch et al., 2014; Larsson & Flach, 2021;
Haberecht et al., 2019). To better analyze the drug and phage resistance patterns in the Hans
Groot Kill, further research is required. A redesign of this study to allow for a high throughput
analysis of many E. coli environmental isolates may provide greater insight into the
antimicrobial and phage resistance characteristics of the typical E. coli strain in the Hans Groot
Kill.
A second limitation is that our study only analyzed E. coli from one environmental
source. The Hans Groot Kill’s E. coli may not represent the E. coli of a rural stream, or even
another urban stream. Whether a stream is in a rural or urban setting has been shown to have

18

significant effects on the stream’s chemistry, pollution levels, and microbiome (Hosen et al.,
2017). To make well supported conclusions and analyze the threat of antimicrobial drug and
phage resistance in bacteria, from a study such as ours, it would be necessary to analyze E. coli
from more streams, in areas with different levels of human development. In short, our study’s
effectiveness could be markedly optimized if its scope were larger.
Environmental phage isolation is another important area for further research. Our small
drop plaque assay proved to be an effective means for visualization of phage infectivity in E. coli
that was significantly less time consuming compared to the more common double agar layer
method of plaque visualization described by Kropinski et al. (2009). Previous research has
shown that phages isolated in hospital settings from patients infected with multi drug resistant E.
coli are able to effectively eradicate clinically isolated E. coli strains in vivo and in vitro
(Rahmani et al., 2015). Even in partially antimicrobial drug-resistant bacterial strains,
environmentally isolated phages can be used synergistically with antimicrobial drugs to control a
phage infection (Valério et al., 2017). This illustrates the importance of phages in effectively
treating drug resistant bacterial infections.
Growth Rate
Our growth rate assay was successful in delineating the point when our E. coli
environmental isolates and lab strains entered their log phase of growth. In all experiments where
phage and antimicrobial susceptibility was tested, we needed to use metabolically active, actively
dividing E. coli, so knowing the start of the log phase was essential to this study’s success. One
important observation was that the E. coli lab strains and environmental isolates were all
observed to enter log phase at about the same time, at 1.5 hours of incubation. Since this time is
common to our E. coli lab strains and environmental isolates, it is reasonable to infer that growth
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rate is conserved across most E. coli strains; thus this 1.5-hour incubation time frame can be used
in future studies for any environmentally isolated E. coli strains.
The difference in growth rates between E. coli environmental isolates and lab strains is
not easily explained from a fitness perspective. We saw that the E. coli environmental isolates
generally had faster growth rates and greater bacteriophage resistance compared to lab strains.
Growth rate is a measure of bacterial fitness; a bacterium with a higher growth rate, all else being
equal, is more fit than a bacterium with a lower growth rate (Pope et al., 2010). Previous research
has indicated that when a bacterium acquires phage resistance, its growth rate actually decreases
(Avrani & Lindell, 2015). Therefore, it is interesting to observe that our E. coli environmental
isolates have acquired phage resistance and yet, display a higher growth rate than our E. coli lab
strains.
Kirby-Bauer Antibiotic Testing
We thought that since the E. coli environmental isolates likely originated from human
feces, they would have been exposed to and acquired resistance to several antimicrobial drugs. It
is intriguing to observe that the E. coli environmental isolates were highly susceptible to four out
of the six antibiotics that were tested. Indeed, tetracycline and nitrofurantoin showed only
intermediate resistance with the E. coli environmental isolates, not full resistance. This indicates
that conventional antibiotics would still be sufficient to treat most infections with E. coli strains
(Anderson et al., 2019).
In recent years, previous studies have shown an increase in drug resistant E. coli in both
clinical and community environments (Ibrahim et al., 2012; Ansari et al., 2015). This increase
has posed tremendous threat to public health because of the ubiquity of E. coli; for example,
pathogenic E. coli causes 80% of urinary tract infections (Croxall et al., 2011). The emergence of
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intermediate resistance towards tetracycline and nitrofurantoin seen in our E. coli environmental
isolates is a troubling indication that these E. coli strains may further develop intermediate and/or
complete resistance to other antimicrobial drugs. Such developments would be of grave concern
to physicians and other medical professionals seeking to treat E. coli infections with common
drugs.

Small Drop Plaque Assay
All three environmental isolates of E. coli displayed complete resistance to T4 phage.
These findings raise several interesting implications. Since our control E. coli lab strains B and C
were highly susceptible to T4 phage, these observations demonstrate that the T4 phage
preparation was infectious as expected. This in turn strongly suggests that the three E. coli
environmental isolates must have acquired a resistance mechanism that was absent in the lab
strains. T4 is an extremely common phage in the environment (Desplats & Krisch, 2003).
Therefore, it is unsurprising that the E. coli environmental isolates expressed high levels of
resistance to T4 phage. Fortunately, there are many different bacteriophage species and strains in
the environment (Rohwer, 2003). It is likely that there is another type of phage that could
successfully infect our E. coli environmental isolates. In addition, there may be temperate phages
that have already infected our environmental isolates and exist as prophages in the E. coli
chromosome (Cieślik et al., 2021; Kasatiya, 1970). These phages would still be capable of being
induced into a full lytic cycle under certain conditions (i.e.: high nutrient levels or following
genotoxic damage) (Anderson et al., 2019).
Studies have shown that prophages are difficult to identify because they are so well
integrated into the bacterial genome (Tang et al., 2021). One method of prophage identification
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uses genome sequencing and comparison to known phage genomes. The tremendous genetic
diversity of bacteriophages and insufficient sequencing data for cross referencing means that
many prophages are missed (ibid.). To solve this problem, Tang et al., (2021) developed
“Prophage Tracer,” an algorithm that uses sequencing data to identify prophages in bacterial
genomes through overlapping split-read alignment in the genome. These recent advances in
prophage identification may fuel future studies in rapidly identifying and inducing lysis in
bacteria infected with temperate phages, expanding our ability to use these phages in phage
therapy.
This study was effective in developing and optimizing the use of a small drop plaque
assay to analyze phage susceptibility in E. coli. This assay can be repeated in the future with lytic
phages purified from the environment from which E. coli strains are isolated, or with
environmentally sourced temperate phages induced into a lytic cycle. Environmental phages will
likely have coevolved with the E. coli environmental isolates. Consequently, environmental
phages will likely be more successful, compared to T4 phage, in inducing lysis in E. coli strains
isolated from environmental sources.

Phage and Antimicrobial Resistance Mechanisms
Encapsulation was a simple and easily testable hypothetical resistance mechanism for us
to analyze in this study. A bacterium’s capsule acts as a barrier that prevents phage and antibiotic
adsorption or entrance into the cell (Soundararajan et al., 2019). Our results clearly demonstrated
that E. coli environmental isolates and lab strains were both encapsulated. These findings
strongly suggest that encapsulation was not a likely phage or antimicrobial resistance mechanism
within our E. coli environmental isolates.
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Phage and antimicrobial resistance can be explained by a number of other subcellular
mechanisms in E. coli. A study by Soundararajan et al. (2019), proposed five mechanisms for
phage resistance: self-protection, genome modification, CRISPR-Cas9, a restriction modification
system, and phage inactivation. Encapsulation is a form of self-protection, but any sort of barrier
around a cell, or a phage receptor modification could also be considered self-protection. Genome
modification describes mechanisms such as superinfection exclusion, wherein an established
virus prevents a secondary infection by the same or a closely related virus (Folimonova et al.,
2012). CRISPR-Cas9 is a mechanism by which a cell genetically “remembers” a previous phage
infection and can thereby target and cleave the intruding phage genome before it can infect the
cell. A restriction modification system is a cellular defense mechanism whereby a cell produces
restriction enzymes that target foreign DNA sequences for degradation. Phage inactivation can
take many forms; one possible mechanism occurs when a phage is inactivated by binding to a
vesicle or outer membrane structure (Soundararajan et al., 2019).
Clearly, bacteria may acquire phage and antimicrobial resistance through many different
mechanisms. Future research to determine specific subcellular phage and antimicrobial
resistance mechanisms may require knockout gene experiments, genome sequencing, or other
genetic analysis (McCloskey et al., 2018). Restriction Enzymes can be identified through DNA
cleavage experiments and methylation site identification (Ryu & Rowsell, 2008).
Lipopolysaccharide (LPS) composition from resistant bacteria and membrane protein mutations
can be identified through SDS page analysis (Filippov et al., 2011). CRISPR is a fairly recently
discovered defense mechanism in bacteria, with considerable ongoing research. One promising
means of determining if CRISPR is active in a bacterium is through the presence of Cas proteins.
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Cas proteins can be identified by comparing a protein’s amino acid sequence to Cas protein
sequences that have been sequenced from other bacteria (Makarova & Koonin, 2015).

Future Research
Our study demonstrated the need for future research on antimicrobial drugs and phage
resistance in E. coli. Future studies should focus on a high throughput analysis of phage and
antimicrobial drug resistance in many E. coli environmental isolates from different
environmental sources. This, combined with an analysis and identification of resistance
mechanisms in E. coli, will enable researchers to make well-founded conclusions about E. coli
phage and antibiotic resistance, and its medical and industrial implications.
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Appendix
Figures & Tables

Figure 1. The Hans Groot Kill. This urban stream is highly contaminated with enteric bacteria.
Shown are our two water sampling sites from which the E. coli environmental isolates were
obtained.
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Figure 2. Lactose broth fermentation test. Left panel, sterile lactose broth tubes containing
Durham tubes. Right panel, in the presence of a lactose fermenting organism, acid is produced
and the pH indicator phenol red turns yellow. Gas is also produced, visible as a bubble in the
inverted Durham tube.
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Figure 3. Quadrant streak of E. coli grown on Eosin Methylene Blue (EMB) agar. EMB agar is
selective for gram-negative enteric bacteria and differential for lactose fermenting bacteria. E.
coli colonies produce a greyish-green metallic sheen on EMB agar.
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Figure 4. Gram stain of E. coli strain C. Pink rods can be observed in this smear, typical of a
Gram-negative cell wall.

37

Figure 5. The bacterial growth curve in a closed system depicting lag, log (exponential growth),
stationary and decline (death) phases.
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Figure 6. Growth rates of E. coli lab strains and environmental isolates. Each E. coli strain was
grown in 5 ml 1.5 Ca2+ TSB in a 37℃-shaker incubator. Absorbance was measured by
spectrophotometry at a wavelength of 600 nm every 30 minutes. Log phase begins at 1.5 hours
of incubation.
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Figure 7. Kirby Bauer antimicrobial drug sensitivity profile of E. coli strain “2A”. A bacterial
lawn was seeded on Mueller-Hinton agar plates, tested against six different antimicrobial drugs:
Tetracycline, Kanamycin, Sulfadimethoxine, Chloramphenicol, Nalidixic Acid, and
Nitrofurantoin; and incubated overnight at 37oC. Each plate contains three antibiotic disks and a
central control disk. Note the clear zones of inhibition around each antibiotic disk. These plates
are representative of the methods used for all E. coli strains.
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Figure 8. Environmental isolates are resistant to T4 lytic phage. A modified small drop plaque
assay was carried out to determine phage susceptibility of E. coli laboratory strains and
environmental isolates, and is shown in duplicate. Sections 1-8 are serial T4 phage dilutions
mixed with E. coli; the sections marked “1” have the highest phage concentration, 1.5*104 pfu/μl
“8” have the lowest phage concentration, 1.5*10-4 pfu/μl and “9” and “10” have no phage. Top
panel: E. coli strain 2A, depicted as representative of our environmental isolates, exhibited
complete resistance to T4 phage as noted by the absence of plaques. Bottom panel: with E. coli
lab strain C, plaques are visible at the highest phage concentrations, which demonstrates high
susceptibility to T4 phage lytic cycle.
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Figure 9. Diagram depicting an encapsulated bacterium. The bacterial capsule is external to the
cell wall and consists of a polysaccharide matrix (Nazir et al., 2019).
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Figure 10. Capsule stains of representative E. coli strains. Bacterial smears were stained
according to Anthony’s method. Left panel, E. coli strain C. Right panel, E. coli strain 2A. The
clear halo surrounding the rod-shaped cells indicates the presence of a capsule (red arrows in
both panels). Both environmental isolates of E. coli and lab strains were found to be
encapsulated.

43

E. coli Environmental Isolates

1

2A

2B

Glucose

+

+

+

Gas

+

+

+

Lysine decarboxylase

-

+

+

Ornithine
decarboxylase

-

+

+

H2S/ Indole

-/-

-/-

-/-

Adonitol

-

-

-

Sorbitol

+

+

+

VP

-

-

-

Dulcitol

-

+

+

Urea

-

-

-

Citrate

-

-

-

Lactose

+

+

+

Arabinose

+

+

+

Table 1. Enterotube identification for the three environmental isolates of E. coli. “+” indicates a
positive result for a test while “-” indicates a negative result. Variation in lysine and ornithine
decarboxylase activity as well as dulcitol fermentation was observed among the isolates.
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Antimicrobial Drug

Target

B

C

1

2A

2B

Tetracycline

Ribosomes

S

S

I

I

I

Kanamycin

Ribosomes

S

S

S

S

S

Sulfadimethoxine

Folate synthesis

S

S

S

S

S

Chloramphenicol

Ribosomes

S

S

S

S

S

Nalidixic Acid

DNA replication

S

S

S

S

S

Nitrofurantoin

rRNA, DNA

S

S

I

I

I

Table 2. Kirby-Bauer antimicrobial drug sensitivity assay in laboratory strains and environmental
isolates of E. coli. “I” indicates intermediate resistance whereas “S” indicates susceptibility to
the antimicrobial drug. Except for intermediate resistance to the drugs Tetracycline and
Nitrofurantoin observed in the environmental isolates, all strains showed high susceptibility to
the other antimicrobial drugs. No strain exhibited complete resistance to any of the drugs tested.
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